SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: M. Ramle who wrote (388)8/22/1997 3:09:00 PM
From: James Silverman   of 10280
 
MR,
From all I know that ruling can't be changed in their favor or at least is highly unlikely.
What you need to understand is that this lawsuit is not all that relevant to even PBIO. They have a strong product line, fastly increasing sales and have simply hammered BSEP in their market. At the very worst, they will owe BSEP on the counterclaim and the few particular PBIO patents in question will not stand. That doesnt imply this will hurt the PBIO product line whatsoever, or that they will have to pull products from the market. So in short, PBIO is rising on their own fundamentals that have nothing to do with the particular patents in question.

Further than that, I don't know what else to add, other than that I feel you are really grasping to connect the fates of the two together and are mistakenly doing such. Also I should add that PBIO used to be a $30+ stock. I own shares in both companies in question (SEPR, PBIO) and place no correlation on the fates of the two, nor do I own one as a hedge for the other.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News